欧洲 · 通讯社与实时数据 · Reuters
Gilead hikes 2026 sales outlook, says Medicare cuts Biktarvy price by 38% starting in 2028
Gilead Sciences hiked its full-year sales outlook on Thursday and reported third-quarter product sales rose 13%, driven by a double-digit percentage jump for its flagship HIV…
在 Reuters 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.reuters.com)
